1,200 articles
Jonathan E. Rosenberg
Jonathan E. Rosenberg is an American medical oncologist specializing in bladder and other genitourinary cancers, and Chief of the Genitourinary Oncology Service at Memorial Sloan Kettering since 2018.
Jordan U. Gutterman
Jordan U. Gutterman is an American oncologist who joined MD Anderson in 1971, led its Biological Therapy Section, and pioneered alpha interferon therapy for hairy-cell leukemia.
Jørgen H. Olsen
Jørgen H. Olsen was a Danish cancer epidemiologist at the Danish Cancer Society, known for his 1995 New England Journal of Medicine study of cancer in parents of children with cancer.
José Baselga
José Baselga (1959–2021) was a Spanish-born medical oncologist who led the development of targeted breast cancer therapies such as trastuzumab and pertuzumab, and served as physician-in-chief of Memorial Sloan Kettering.
José R. Conejo-García
José R. Conejo-García is a Spanish-trained physician-scientist in tumor immunology, professor at Duke University since 2024 after chairing immunology at Moffitt Cancer Center, known for ovarian cancer CAR T-cell therapy.
Josep Tabernero
Josep Tabernero is a Spanish medical oncologist specializing in gastrointestinal cancers, who heads medical oncology at Vall d'Hebron University Hospital and directs the Vall d'Hebron Institute of Oncology in Barcelona.
Joseph A. Sparano
Joseph A. Sparano is an American medical oncologist who has led hematology and medical oncology at Mount Sinai since 2021 and led the TAILORx breast cancer trial.
Joseph F. Fraumeni
Joseph F. Fraumeni was an American cancer epidemiologist at the National Cancer Institute who co-discovered Li-Fraumeni syndrome and founded its Division of Cancer Epidemiology and Genetics.
Joseph H. Burchenal
Joseph H. Burchenal (Joseph Holland Burchenal, 1912–2006) was an American oncologist who helped found modern cancer chemotherapy, bringing 6-mercaptopurine to the first long-term remissions of childhood leukemia.
Joseph M. Connors
Joseph M. Connors is a Canadian medical oncologist who spent his career at BC Cancer in Vancouver, leading the ECHELON-1 trial that changed first-line treatment of advanced Hodgkin lymphoma.
Joseph P. Neglia
Joseph P. Neglia, also published as Joseph Neglia, is an American pediatric hematologist-oncologist at the University of Minnesota known for defining second-cancer risk in childhood cancer survivors.
Joseph R. Bertino
Joseph R. Bertino was an American physician-scientist in cancer pharmacology whose research on methotrexate resistance led to leukemia and lymphoma treatments; he served as president of ASCO and the AACR.
Joseph S. Pagano
Joseph S. Pagano is an American physician-scientist and tumor virologist at UNC-Chapel Hill, where since 1965 he has studied Epstein-Barr virus and cancer and founded the Lineberger Cancer Center.
JosephF. Fraumeni
Joseph F. Fraumeni, Jr. (1933–2026) was an American cancer epidemiologist who co-discovered Li-Fraumeni syndrome and founded the National Cancer Institute's Division of Cancer Epidemiology and Genetics.
Joyce M. Slingerland
Joyce M. Slingerland, also known as Joyce Slingerland, is a Canadian-trained physician-scientist credited with discovering the cell-cycle inhibitor p27, and has been Professor of Oncology at Georgetown University since 2020.
Juan W. Valle
Juan W. Valle is a Peruvian-born, British-based medical oncologist and Professor Emeritus at the University of Manchester, known for the ABC-02 and TOPAZ-1 trials in biliary tract cancer.
Judith M. Bliss
Judith M. Bliss is a British medical statistician, Professor of Clinical Trials at the Institute of Cancer Research, London, directing its Clinical Trials and Statistics Unit.
Julian Peto
Julian Peto is a British cancer epidemiologist at the London School of Hygiene & Tropical Medicine known for work on asbestos, cervical screening, and breast cancer genetics.
Julie R. Brahmer
Julie R. Brahmer, also published as Julie Brahmer, is an American medical oncologist at Johns Hopkins who led the first-in-human trial of nivolumab for lung cancer.
Julien Sage
Julien Sage is a cancer biologist and professor of genetics and pediatrics at Stanford University, known for research on the RB pathway and small cell lung cancer.
Julien Taïeb
Julien Taïeb, also written Julien Taieb, is a French physician and professor at Université Paris Cité who heads digestive oncology at the Hôpital européen Georges-Pompidou in Paris.
Jun‐Lin Guan
Jun-Lin Guan is a cancer biologist and professor at the University of Cincinnati known for identifying focal adhesion kinase and showing that autophagy can promote tumor development.
Jürgen Knoblich
Jürgen Knoblich (born 1963) is a German developmental biologist at IMBA in Vienna whose laboratory introduced cerebral organoids, human stem-cell models of brain development, in 2013.
Justin M. Balko
Justin M. Balko is an American translational cancer researcher at Vanderbilt University Medical Center who studies why breast cancers resist chemotherapy and immunotherapy and which biomarkers predict response.
Justin Stebbing
Justin Stebbing is a British oncologist, a professor at Imperial College London and Anglia Ruskin University who works on cancer immunotherapy and led breast cancer drug target research.
K. Dane Wittrup
K. Dane Wittrup, known as Dane Wittrup, is a chemical and biological engineer at MIT who developed yeast surface display and applies protein engineering to cancer immunotherapy.
Kai Tan
Kai Tan is a computational and systems biologist who studies blood formation and childhood cancer, directing the Center for Single Cell Biology at Children's Hospital of Philadelphia.
Kairbaan Hodivala‐Dilke
Kairbaan Hodivala-Dilke (Kairbaan M. Hodivala-Dilke) is a cell biologist studying tumor angiogenesis who is Professor of the Tumour Microenvironment at Barts Cancer Institute, Queen Mary University of London.
Karen A. Gelmon
Karen A. Gelmon is a Canadian medical oncologist and clinician-scientist known for breast cancer research and clinical trials of new cancer therapies, based at BC Cancer in Vancouver.
Karen Canfell
Karen Canfell is an Australian cancer epidemiologist and University of Sydney professor whose modeling underpinned Australia's 2017 HPV screening shift and the WHO cervical cancer elimination strategy.